UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307C952. A total of 5 filers reported holding UNITED THERAPEUTICS CORP DEL in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $135 | -69.4% | 600 | -70.0% | 0.00% | – |
| Q2 2023 | $441 | -73.4% | 2,000 | -73.0% | 0.00% | -100.0% |
| Q1 2023 | $1,657 | +92.2% | 7,400 | +138.7% | 0.00% | 0.0% |
| Q4 2022 | $862 | -100.0% | 3,100 | -79.1% | 0.00% | -75.0% |
| Q3 2022 | $3,098,000 | +448.3% | 14,800 | +516.7% | 0.00% | +300.0% |
| Q2 2022 | $565,000 | -85.9% | 2,400 | -89.3% | 0.00% | -75.0% |
| Q1 2022 | $4,018,000 | +4572.1% | 22,400 | +5500.0% | 0.00% | – |
| Q4 2021 | $86,000 | -83.9% | 400 | -86.2% | 0.00% | – |
| Q3 2021 | $535,000 | +2.9% | 2,900 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $520,000 | – | 2,900 | +3927.8% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 72 | +5.9% | 0.00% | -100.0% |
| Q4 2020 | $1,032,000 | +510.7% | 68 | +385.7% | 0.00% | – |
| Q2 2020 | $169,000 | -68.7% | 14 | -75.4% | 0.00% | -100.0% |
| Q1 2020 | $540,000 | -65.4% | 57 | -67.8% | 0.00% | -66.7% |
| Q4 2019 | $1,559,000 | +77.8% | 177 | +60.9% | 0.00% | +50.0% |
| Q3 2019 | $877,000 | -41.1% | 110 | -42.4% | 0.00% | -50.0% |
| Q2 2019 | $1,490,000 | -64.4% | 191 | -46.5% | 0.00% | -66.7% |
| Q1 2019 | $4,190,000 | +237.6% | 357 | +213.2% | 0.01% | +200.0% |
| Q4 2018 | $1,241,000 | -73.1% | 114 | -68.4% | 0.00% | -73.3% |
| Q3 2018 | $4,616,000 | +64.5% | 361 | +45.6% | 0.02% | +36.4% |
| Q2 2018 | $2,806,000 | +56020.0% | 248 | +1358.8% | 0.01% | – |
| Q1 2018 | $5,000 | -37.5% | 17 | -79.3% | 0.00% | – |
| Q4 2017 | $8,000 | -87.7% | 82 | -61.0% | 0.00% | -100.0% |
| Q3 2017 | $65,000 | -41.4% | 210 | -44.9% | 0.00% | -40.0% |
| Q2 2017 | $111,000 | +14.4% | 381 | +929.7% | 0.01% | +25.0% |
| Q1 2017 | $97,000 | +304.2% | 37 | -60.2% | 0.00% | +300.0% |
| Q4 2016 | $24,000 | -38.5% | 93 | -7.9% | 0.00% | -66.7% |
| Q3 2016 | $39,000 | -20.4% | 101 | -1.0% | 0.00% | 0.0% |
| Q2 2016 | $49,000 | +63.3% | 102 | +20.0% | 0.00% | +50.0% |
| Q1 2016 | $30,000 | -31.8% | 85 | +214.8% | 0.00% | -33.3% |
| Q4 2015 | $44,000 | -77.6% | 27 | -81.1% | 0.00% | -78.6% |
| Q3 2015 | $196,000 | +752.2% | 143 | +450.0% | 0.01% | +600.0% |
| Q2 2015 | $23,000 | +283.3% | 26 | +4.0% | 0.00% | +100.0% |
| Q1 2015 | $6,000 | +20.0% | 25 | -73.4% | 0.00% | 0.0% |
| Q4 2014 | $5,000 | – | 94 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 22,400 | $5,016,704 | 0.02% |
| JANE STREET GROUP, LLC | 63,000 | $14,109,480 | 0.01% |
| SIMPLEX TRADING, LLC | 7,400 | $1,657 | 0.00% |
| JPMORGAN CHASE & CO | 19,200 | $4,300,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |